Ambassador Shimokawa’s Visit to Solvay Brussels School of Economics & Management
2022/5/19
On May 17, Ambassador Shimokawa visited the Solvay Brussels School of Economics & Management, part of the Université libre de Bruxelles. The school launches an Advanced Master in Biotech & MedTech Ventures starting in September this year. Ambassador Shimokawa was given a presentation about this master’s program by Mr. Bruno van Pottelsberghe, Dean of Solvay Brussels School, and Co-Academic Directors Mr. Marc Dechamps and Mr. Philip Vergauwen among others, who run the program.
While Belgium is widely considered to be one of the leading hubs of European life sciences, this master’s program aims to foster start-up entrepreneurs in the Biotech and MedTech fields not only in Belgium but also at the international level. To this end, many business people currently active in related industries will feature as lecturers of the master’s program. Officials from the Solvay Brussels School also expressed their expectation that through the master's program, partnership will strengthen with Japan, where research and business in the fields of Biotech and MedTech are thriving.
Website of Advanced Master in Biotech & MedTech Ventures
https://exed.solvay.edu/en/11-program/1050-advanced-master-in-biotech-and-medtech-ventures
While Belgium is widely considered to be one of the leading hubs of European life sciences, this master’s program aims to foster start-up entrepreneurs in the Biotech and MedTech fields not only in Belgium but also at the international level. To this end, many business people currently active in related industries will feature as lecturers of the master’s program. Officials from the Solvay Brussels School also expressed their expectation that through the master's program, partnership will strengthen with Japan, where research and business in the fields of Biotech and MedTech are thriving.
Website of Advanced Master in Biotech & MedTech Ventures
https://exed.solvay.edu/en/11-program/1050-advanced-master-in-biotech-and-medtech-ventures